2 completed, 2 enrolling by invitation, 1 active not recruiting, 1 not yet recruiting. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1 |
Follow Endogenex, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes pulsENDO Therapy - Diabetes Type 2, Diabetes | Not applicable | Not yet recruiting | Endogenex, Inc. | 320 | 2027-01-01 | 2026-08-18 |
| Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study Endogenex System - Type 2 Diabetes Mellitus, Type2diabetes | Not applicable | Enrolling by invitation | Endogenex, Inc. | 50 | 2026-09-01 | 2026-10-19 |
| Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry) Type 2 Diabetes Mellitus (T2DM), Type2Diabetes | Enrolling by invitation | Endogenex, Inc. | 500 | 2026-03-11 | 2026-07-01 | |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes Endogenex Treatment, Sham Procedure - Type 2 Diabetes Mellitus, Type2diabetes | Not applicable | Active not recruiting | Endogenex, Inc. | 350 | 2024-05-01 | 2026-08-05 |
| Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes The Endogenex Device - Diabetes, Diabetes Type 2 | Not applicable | Completed | Endogenex, Inc. | 20 | 2021-10-29 | 2025-12-22 |
| Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes The DyaMX Device - Type 2 Diabetes | Not applicable | Completed | Endogenex, Inc. | 65 | 2021-04-20 | 2026-01-22 |
Diabetes Mellitus, Type 2 (6) · Diabetes Mellitus (5) · Body Weight Changes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
Australia (4) · United States (4)
Adrian Sartoretto, MD (1) · Daniel DeMarco, M.D. (1) · Daniel DeMarco, MD (1) · Lian Cunningham, MD, PhD (1)